Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...

This study presents valuable findings for identifying biotypes of depression patients using white matter measures, which are under-utilised and under-appreciated in current biological and ...

In October 2025, Tonix presented an update at the Japan Society for Transplantation annual congress, highlighting Phase 1 safety and pharmacokinetic and pharmacodynamic results and outlining next ...

AI tools like ChatGPT assist in creating content, offering new income opportunities. AI-generated art and YouTube videos can provide passive income sources. AI can help design, build, and market ...

Students love AI — but isn't that cheating? The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US A ...

TONMYA (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to ...